This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Mar;22(3):179.

doi: 10.1038/d41573-023-00018-8.

CRISPR base editing protects the heart

PMID: 36725926
DOI: 10.1038/d41573-023-00018-8

Comment

CRISPR base editing protects the heart

Alex Eccleston. Nat Rev Drug Discov. 2023 Mar.

. 2023 Mar;22(3):179.

doi: 10.1038/d41573-023-00018-8.

Author

PMID: 36725926
DOI: 10.1038/d41573-023-00018-8

No abstract available

PubMed Disclaimer

Comment on

Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease.
Lebek S, Chemello F, Caravia XM, Tan W, Li H, Chen K, Xu L, Liu N, Bassel-Duby R, Olson EN. Lebek S, et al. Science. 2023 Jan 13;379(6628):179-185. doi: 10.1126/science.ade1105. Epub 2023 Jan 12. Science. 2023. PMID: 36634166 Free PMC article.

References

1. Lebek, S. et al. Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease. Science 379, 179–185 (2023) - PubMed - DOI

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group